查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1696270

日本心臟手術器械市場 - 2025 至 2033 年

Japan Cardiac Surgery Instruments Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年日本心臟手術器械市場規模達到 8,268 萬美元，預計到 2033 年將達到 1.6665 億美元，在 2025-2033 年預測期內的複合年成長率為 8.1%。

心臟手術器械是高度專業化的工具，旨在協助心胸外科醫師對心臟和主要血管進行複雜的手術。這些儀器對於確保手術過程中的精確度、控制力和安全性至關重要，因為它們有助於操縱精細的組織、進行精確的切口和固定縫合。由於心臟手術通常需要對動脈、瓣膜和腔體等結構進行細緻處理，這些器械在提高手術效率和減少併發症方面發揮著至關重要的作用。

這些工具用於各種關鍵手術，包括冠狀動脈繞道手術 (CABG)、心臟瓣膜修復或置換、心臟移植和先天性心臟缺陷矯正。每種手術都需要根據手術的複雜程度來客製化特定的器械，例如血管鉗、牽開器、鑷子和持針器。心臟手術器械（包括機器人輔助和微創工具）的不斷進步，透過縮短恢復時間並降低術後風險進一步改善了患者的治療效果。

市場動態：

促進因素與約束因素

心血管疾病發生率上升

日本心血管疾病（CVD）發生率的不斷上升是推動心臟手術器械需求的主要因素。日本是世界上人口老化程度最高的國家之一，超過28%的居民年齡在65歲以上，這使他們更容易患上冠狀動脈疾病 (CAD)、心臟衰竭和瓣膜疾病等心臟疾病。

根據2024年發布的研究報告，日本心臟衰竭發生率不斷上升，預計2030年將達到130萬例，將大大推動日本心臟手術器械市場的發展。隨著心臟衰竭變得越來越普遍，對心臟手術的需求也隨之增加，包括冠狀動脈繞道手術 (CABG)、心臟瓣膜修復/置換和其他心臟手術。這直接影響到用於治療心臟衰竭患者和改善其生活品質的專門手術器械的需求。

由於生活方式因素導致的心血管疾病負擔不斷增加，再加上診斷和治療的改善，大大推動了日本對心臟手術器械的需求。隨著越來越多的患者接受外科手術和微創手術，醫院和外科中心正在投資尖端工具，這進一步推動了市場的成長。

先進手術器械價格昂貴

先進手術器械價格昂貴是日本心臟手術器械市場發展的一大限制因素。對於機器人輔助系統和微創設備等技術來說尤其如此，這些技術可以提供更高的精度和更快的恢復時間，但價格也相當昂貴。這些先進技術所需的初始投資可能非常昂貴，特別是對於預算有限的小型醫院或醫療中心而言。在某些地區，高昂的前期成本使得醫院難以廣泛採用這些尖端工具。

對日本6家醫院實施的經皮腔內冠狀動脈成形術（PTCA）的成本分析顯示，每次手術的人工成本在65,000日元至98,000日元之間。這凸顯了心臟介入治療所需的大量資金投入。此外，每次手術一次性材料的費用從 1,000 日元到 39,000 日元不等，包括勞動力、材料和資本投資在內的總成本在 95,000 日元到 224,000 日元之間。這些成本的差異反映了地區預算限制和醫院之間的不同財務優先順序如何影響其投資先進技術的能力，從而限制其採用和融入臨床實踐。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 心血管疾病發生率上升
      • 心臟手術的技術進步
    • 限制
      • 先進手術器械價格昂貴
      • 嚴格的監管要求
    • 機會
      • 微創手術需求不斷成長
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有銷售量最大的品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：日本心臟手術器械市場（依產品類型）

  • 手術器械
    • 鉗子
    • 夾具
    • 手術刀
    • 剪刀
    • 持針器
    • 其他
  • 心臟監測儀器
  • 冠狀動脈繞道手術 (CABG) 器械
  • 心臟瓣膜修復和置換器械
  • 內視鏡和機器人器械
  • 心肺旁路設備
  • 其他

第 6 章：日本心臟手術器械市場（依應用）

  • 冠狀動脈繞道手術
  • 心臟瓣膜手術
  • 小兒外科
  • 心臟移植
  • 其他

第 7 章：日本心臟手術器械市場（依最終用戶分類）

  • 醫院和心臟中心
  • 門診手術中心
  • 其他

第 8 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第9章：公司簡介

  • Medtronic
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Johnson & Johnson (Ethicon)
  • Abbott.
  • Siemens Healthineers
  • GE Healthcare
  • Boston Scientific Corporation
  • Terumo Cardiovascular Systems Corporation.
  • Stryker
  • Koninklijke Philips NV
  • Edwards Lifesciences Corporation.

第 10 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 11 章：附錄

簡介目錄
Product Code: MD9377

The Japan cardiac surgery instruments market reached US$ 82.68 million in 2024 and is expected to reach US$ 166.65 million by 2033, growing at a CAGR of 8.1 % during the forecast period 2025-2033.

Cardiac surgery instruments are highly specialized tools designed to assist cardiothoracic surgeons in performing complex procedures on the heart and major blood vessels. These instruments are essential for ensuring precision, control, and safety during surgery, as they help manipulate delicate tissues, make accurate incisions, and secure sutures. Since heart surgeries often require meticulous handling of structures like arteries, valves, and chambers, these instruments play a crucial role in improving surgical efficiency and reducing complications.

These tools are used in a variety of critical procedures, including coronary artery bypass grafting (CABG), heart valve repair or replacement, heart transplants, and congenital heart defect corrections. Each of these surgeries demands specific instruments tailored to the procedure's complexity, such as vascular clamps, retractors, forceps, and needle holders. The continuous advancement of cardiac surgery instruments, including robotic-assisted and minimally invasive tools, has further enhanced patient outcomes by reducing recovery times and minimizing post-operative risks.

Market Dynamics: Drivers & Restraints

Rising Incidence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases (CVDs) in Japan is a major factor driving demand for cardiac surgery instruments. Japan has one of the world's oldest populations, with over 28% of its residents aged 65 and older, making them more susceptible to heart diseases such as coronary artery disease (CAD), heart failure, and valve disorders.

According to the research study published in 2024, the rising prevalence of heart failure in Japan, projected to reach 1.3 million cases by 2030, is significantly driving the Japan cardiac surgery instruments market. As heart failure becomes more common, the demand for cardiac surgeries including coronary artery bypass grafting (CABG), heart valve repairs/replacements, and other heart surgeries increases. This directly impacts the need for specialized surgical instruments designed to treat heart failure patients and improve their quality of life.

The increasing burden of CVDs due to lifestyle factors, coupled with improvements in diagnosis and treatment, is significantly driving the demand for cardiac surgery instruments in Japan. As more patients undergo surgical and minimally invasive procedures, hospitals and surgical centers are investing in cutting-edge tools, which is further boosting the growth of the market.

High Cost of Advanced Surgical Instruments

The high cost of advanced surgical instruments is a major constraint in the Japanese cardiac surgery instruments market. This is particularly true for technologies like robotic-assisted systems and minimally invasive devices, which offer improved precision and faster recovery times but come with a significant price tag. The initial investment required for these advanced technologies can be prohibitively expensive, especially for smaller hospitals or healthcare centers that are already working with limited budgets. In certain regions, the high upfront costs make it challenging for hospitals to widely adopt these cutting-edge tools.

A cost analysis of percutaneous transluminal coronary angioplasty (PTCA) performed at six Japanese hospitals showed that labor costs ranged from yen 65,000 to yen 98,000 per procedure. This highlights the significant financial commitment required for cardiac interventions. In addition, the costs for disposable materials varied from yen 1,000 to yen 39,000 per procedure, bringing the total cost including labor, materials, and capital investment to between yen 95,000 and yen 224,000. The variation in these costs reflects how regional budget constraints and differing financial priorities among hospitals can impact their ability to invest in advanced technologies, limiting their adoption and integration into clinical practices.

Segment Analysis

The Japan cardiac surgery instruments market is segmented based on product type, application, and end-user.

Product Type:

The coronary artery bypass grafting (CABG) segment in the product type is expected to dominate Japan cardiac surgery instruments market share

The coronary artery bypass grafting (CABG) segment is a critical component of the Japan cardiac surgery instruments market, driven by the high prevalence of coronary artery disease (CAD) in the country. CABG is one of the most common cardiac surgical procedures, used to treat severe cases of CAD where coronary arteries become narrowed or blocked, restricting blood flow to the heart muscle. This procedure is typically required when other treatments, such as medication or angioplasty, are not sufficient to restore normal blood flow.

Furthermore, key players in the industry product launches drive this segment's growth in the Japan cardiac surgery instruments market. For instance, in August 2024, DePuy Synthes, the orthopedics division of Johnson & Johnson and part of Johnson & Johnson MedTech, launched the MatrixSTERNUM Fixation System. This plate and screw fixation system is specifically designed to stabilize and secure the front part of the chest wall after surgeries like open-heart surgery and thoracic surgery. The MatrixSTERNUM system addresses a critical need in the cardiac and thoracic surgery market by offering a more efficient and effective solution for post-surgical stabilization.

The introduction of advanced systems like the MatrixSTERNUM Fixation System is driving innovation in the Japan cardiac surgery instruments market. As Japan experiences an increasing number of cardiac and thoracic surgeries, hospitals are seeking more efficient, reliable, and patient-friendly solutions for surgical stabilization. These factors have solidified the segment's position in the Japan cardiac surgery instruments market.

Competitive Landscape

The major players in the Japan cardiac surgery instruments market include Medtronic, Johnson & Johnson (Ethicon), Abbott., Siemens Healthineers, GE Healthcare, Boston Scientific Corporation, Terumo Cardiovascular Systems Corporation., Stryker, Koninklijke Philips N.V., and Edwards Lifesciences Corporation among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan cardiac surgery instruments market report delivers a detailed analysis with 40+ key tables, more than 30 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Incidence of Cardiovascular Diseases
      • 3.1.1.2. Technological Advancements in Cardiac Surgery
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Advanced Surgical Instruments
      • 3.1.2.2. Stringent Regulatory Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Rising Demand for Minimally Invasive Surgery
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Japan Cardiac Surgery Instruments Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Surgical Instruments*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Forceps
    • 5.2.4. Clamps
    • 5.2.5. Scalpels
    • 5.2.6. Scissors
    • 5.2.7. Needle Holders
    • 5.2.8. Others
  • 5.3. Cardiac Monitoring Instruments
  • 5.4. Coronary Artery Bypass Grafting (CABG) Instruments
  • 5.5. Heart Valve Repair & Replacement Instruments
  • 5.6. Endoscopic and Robotic Instruments
  • 5.7. Cardiopulmonary Bypass Equipment
  • 5.8. Others

6. Japan Cardiac Surgery Instruments Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Coronary Artery Bypass Grafting*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Heart Valve Surgery
  • 6.4. Pediatric Surgery
  • 6.5. Heart Transplant
  • 6.6. Others

7. Japan Cardiac Surgery Instruments Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals and Cardiac Centers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgery Centers
  • 7.4. Others

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Medtronic *
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio
      • 9.1.2.1. Product Description
      • 9.1.2.2. Product Key Performance Indicators (KPIs)
      • 9.1.2.3. Historic and Forecasted Product Sales
      • 9.1.2.4. Product Sales Volume
    • 9.1.3. Financial Overview
      • 9.1.3.1. Company Revenue's
      • 9.1.3.2. Geographical Revenue Shares
      • 9.1.3.3. Revenue Forecasts
    • 9.1.4. Key Developments
      • 9.1.4.1. Mergers & Acquisitions
      • 9.1.4.2. Key Product Development Activities
      • 9.1.4.3. Regulatory Approvals, etc.
    • 9.1.5. SWOT Analysis
  • 9.2. Johnson & Johnson (Ethicon)
  • 9.3. Abbott.
  • 9.4. Siemens Healthineers
  • 9.5. GE Healthcare
  • 9.6. Boston Scientific Corporation
  • 9.7. Terumo Cardiovascular Systems Corporation.
  • 9.8. Stryker
  • 9.9. Koninklijke Philips N.V.
  • 9.10. Edwards Lifesciences Corporation.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us